Merck Contracts & Agreements

232 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Merck & Co., Inc. Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Merck
Pharmaceuticals
NY
2025
Merck & Co., Inc. Executive Incentive Plan (Amended and Restated Effective January 1, 2025)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2025
Indenture Agreement among MSD Netherlands Capital B.V., Merck & Co., Inc., and U.S. Bank Trust National Association (May 30, 2024)
Indenture Agreements
Merck
Pharmaceuticals
NY
2024
MSD Netherlands Capital B.V. 3.250% Notes Due 2032 Officers’ Certificate under Indenture with Merck & Co., Inc. and U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
NY
2024
MSD Netherlands Capital B.V. 3.500% Notes Due 2037 Officers’ Certificate under Indenture with Merck & Co., Inc. and U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
NY
2024
MSD Netherlands Capital B.V. 3.700% Notes Due 2044 Officers’ Certificate
Note Agreements
Merck
Pharmaceuticals
NY
2024
MSD Netherlands Capital B.V. 3.750% Notes Due 2054 Officers’ Certificate under Indenture with Merck & Co., Inc. and U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
NY
2024
2017 Non-Qualified Stock Option Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
NJ
2024
2019 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Stock Agreements
Merck
Pharmaceuticals
2024
Merck & Co., Inc. U.S. Separation Benefits Plan (Amended and Restated as of January 1, 2019)
Severance Agreements
Merck
Pharmaceuticals
NJ
2024
2020 Non-Qualified Stock Option Terms and Conditions under the Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2024
2020 Restricted Stock Unit Award Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2024
2021 Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Stock Agreements
Merck
Pharmaceuticals
2024
2021 Retention Restricted Stock Unit Grant Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2024
2022 Restricted Stock Unit Grant Terms for Chirfi Guindo under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2024
2022 Sign-On Performance Share Unit Award Agreement for Chirfi Guindo under the Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2024
Merck & Co., Inc. 2023 Non-Qualified Stock Option Grant Terms under 2019 Incentive Stock Plan
Stock Agreements
Merck
Pharmaceuticals
NJ
2024
2022 Performance Share Unit Award Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2024
2023 Performance Share Unit Award Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2024
Merck Sharp & Dohme LLC Offer Letter to Chirfi Guindo for Chief Marketing Officer Position
Employment Agreements
Merck
Pharmaceuticals
2024
Merck & Co., Inc. 4.050% Notes Due 2028 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 4.300% Notes Due 2030
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 4.500% Notes Due 2033 Officers’ Certificate under Indenture with U.S. Bank Trust National Association
Indenture Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 4.900% Notes Due 2044 Officers’ Certificate under Indenture with U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 5.000% Notes Due 2053 Officers’ Certificate
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 5.150% Notes Due 2063 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2023
2017 Non-Qualified Stock Option Terms and Conditions under the Merck & Co., Inc. 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
NJ
2023
2019 Non-Qualified Stock Option Terms for Merck & Co., Inc. Employees under the 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. U.S. Separation Benefits Plan (Amended and Restated as of January 1, 2019)
Severance Agreements
Merck
Pharmaceuticals
NJ
2023
2019 CEO Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
2023
2019 Restricted Stock Unit Award Terms under the Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2023
2020 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2023
2020 CEO Stock Option Grant Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2023
2020 Restricted Stock Unit Award Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2023
2020 Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2023
2020 CEO Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
2023
2021 CEO Stock Option Grant Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2023
2021 Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Stock Agreements
Merck
Pharmaceuticals
2023
2021 CEO Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
2023
2021 Special Retention Restricted Stock Unit Terms and Conditions under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2023
2022 Executive Chairman Restricted Stock Unit Grant Agreement under the Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2023
2022 Restricted Stock Unit Grant Terms and Conditions for Chirfi Guindo under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2023
2022 Sign-On Performance Share Unit Award Agreement for Chirfi Guindo under the Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2023
Merck Sharp & Dohme LLC Offer Letter to Chirfi Guindo for Chief Marketing Officer Position
Employment Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. Plan for Deferred Payment of Directors' Compensation (Amended and Restated January 1, 2022)
Compensation Agreements
Merck
Pharmaceuticals
2022
Merck & Co., Inc. 2022 Non-Qualified Stock Option Grant Terms under 2019 Incentive Stock Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
NJ
2022
2022 Restricted Stock Unit Award Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2022
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 1.700% Notes Due 2027
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 1.900% Notes Due 2028
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.150% Notes Due 2031
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.750% Notes Due 2051
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.900% Notes Due 2061
Note Agreements
Merck
Pharmaceuticals
NY
2021
Description of Merck & Co., Inc. Common Stock Registered under Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Merck
Pharmaceuticals
2021
Description of Merck & Co., Inc. 1.125% Notes Due 2021, 1.875% Notes Due 2026, and 2.500% Notes Due 2034
Note Agreements
Merck
Pharmaceuticals
NY
2021
Description of Merck & Co., Inc. 0.500% Notes Due 2024 and 1.375% Notes Due 2036
Note Agreements
Merck
Pharmaceuticals
NY
2021
2021 Restricted Stock Unit Grant Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2021
2021 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 0.750% Notes Due 2026
Note Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 1.450% Notes Due 2030 under Indenture
Note Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.350% Notes Due 2040
Note Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.450% Notes Due 2050 under Indenture
Indenture Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Deferral Program (Amended and Restated Effective December 1, 2019)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2020
Merck & Co., Inc. Amended and Restated Plan for Deferred Payment of Directors' Compensation (Effective January 1, 2020)
Compensation Agreements
Merck
Pharmaceuticals
2020
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.900% Notes Due 2024
Note Agreements
Merck
Pharmaceuticals
NY
2019
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 3.400% Notes Due 2029
Note Agreements
Merck
Pharmaceuticals
NY
2019
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 3.900% Notes Due 2039
Note Agreements
Merck
Pharmaceuticals
NY
2019
Merck & Co., Inc. Officers’ Certificate Establishing 4.000% Notes Due 2049 under Indenture
Indenture Agreements
Merck
Pharmaceuticals
NY
2019
Merck & Co., Inc. U.S. Separation Benefits Plan (Amended and Restated as of January 1, 2019)
Severance Agreements
Merck
Pharmaceuticals
NJ
2019
Severance Agreement and General Release between Merck Sharp & Dohme Corp. and Adam H. Schechter (December 1, 2018)
Severance Agreements
Merck
Pharmaceuticals
2019
Merck Sharp & Dohme Corp. Executive Offer Letter to Jennifer Zachary (March 16, 2018)
Employment Agreements
Merck
Pharmaceuticals
2019
2018 Restricted Stock Unit Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2018
Merck & Co., Inc. Amended and Restated Plan for Deferred Payment of Directors’ Compensation (Effective January 1, 2018)
Compensation Agreements
Merck
Pharmaceuticals
2018
Merck & Co., Inc. Deferral Program (Amended and Restated Effective December 1, 2015)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2017
2016 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2017
2016 Restricted Stock Unit Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2017
2016 Performance Share Unit Award Terms under Merck & Co., Inc. 2010 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2017
Merck & Co., Inc. U.S. Separation Benefits Plan (Amended and Restated as of January 1, 2017)
Severance Agreements
Merck
Pharmaceuticals
NJ
2017
2015 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2016
2015 Performance Share Unit Award Terms under Merck & Co., Inc. 2010 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2016
2015 Restricted Stock Unit Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2016
Merck & Co., Inc. 2014 Restricted Stock Unit Grant Terms under 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2015
2014 Performance Share Unit Award Terms under the Merck & Co., Inc. 2010 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2015
Merck & Co., Inc. U.S. Separation Benefits Plan (Amended and Restated as of November 15, 2014)
Severance Agreements
Merck
Pharmaceuticals
NJ
2015
2014 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2014
2014 Performance Share Unit Award Terms under the Merck & Co., Inc. 2010 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2014
Terms for 2014 Restricted Stock Unit Grants under the Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2014
Stock and Asset Purchase Agreement between Bayer AG and Merck & Co., Inc. (May 5, 2014)
Purchase Agreements
Merck
Pharmaceuticals
NY
2014
Merck & Co., Inc. Offer Letter to Robert M. Davis for Executive Vice President & CFO Position
Employment Agreements
Merck
Pharmaceuticals
2014
Merck & Co., Inc. Deferral Program (Amended and Restated Effective January 1, 2013)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. 2011 & 2012 Performance Share Unit Terms under 2010 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. 2010 Incentive Stock Plan Restricted Stock Unit (RSU) Award Terms (2013 Onward)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2013
Third Supplemental Indenture among Merck Sharp & Dohme Corp., Schering Corporation, Merck & Co., Inc., and U.S. Bank Trust National Association, dated May 1, 2012
Indenture Agreements
Merck
Pharmaceuticals
2012
2012 Performance Share Unit Terms under Merck & Co., Inc. 2010 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. 2012 Non-Qualified Stock Option Terms under 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2012
Merck & Co., Inc. 2012 Restricted Stock Unit Terms under 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2012
Merck & Co., Inc. Separation Program Summary for Legacy Merck Rebadged Employees (Effective January 1, 2012)
Separation Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. Separation Program Summary for Separated Retirement Eligible Employees
Separation Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. Separation Program Information for Legacy Merck Separated Employees (2012)
Separation Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. Separation Program Information for Bridge-Eligible Legacy Employees
Separation Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. Separation Program Summary for Legacy Schering Rebadged Employees
Separation Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. Separation Program Summary for Legacy Schering Separated Retirement Eligible Employees
Separation Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. Separation Program Information for Legacy Schering Separated Employees (Effective January 1, 2012)
Separation Agreements
Merck
Pharmaceuticals
2012
2011 Restricted Stock Unit Terms for Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2011
Merck & Co., Inc. 2011 Non-Qualified Stock Option Terms under 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
NJ
2011
2011 Restricted Stock Unit Award Terms for Richard T. Clark under Merck & Co., Inc. 2010 Incentive Stock Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2011
2011 Performance Share Unit Terms under Merck & Co., Inc. 2010 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2011
Second Amendment to Distribution Agreement among Centocor Ortho Biotech Inc., CNA Development LLC, Cilag GmbH International, Janssen Biologics (Ireland), and Schering-Plough...
Distribution Agreements
Merck
Pharmaceuticals
PA
2011
Master Termination Agreement and Release among Merck & Co., Inc., Merck Sharp & Dohme Corp., Sanofi-Aventis, and Merial Limited (March 21, 2011)
Termination Agreements
Merck
Pharmaceuticals
NY
2011
Merck Sharp & Dohme Special Separation Program for Separated Employees (2010 Revision)
Separation Agreements
Merck
Pharmaceuticals
2011
Merck Sharp & Dohme Corp. Special Separation Program for 'Bridged' Employees (Effective October 1, 2010)
Separation Agreements
Merck
Pharmaceuticals
2011
Merck Sharp & Dohme Corp. Special Separation Program for Separated Retirement Eligible Employees (2010 Revision)
Separation Agreements
Merck
Pharmaceuticals
2011
Merck & Co., Inc. 2010 Non-Employee Directors Stock Option Plan
Stock Agreements
Merck
Pharmaceuticals
NJ
2011
Merck & Co., Inc. Plan for Deferred Payment of Directors’ Compensation (Amended and Restated December 1, 2010)
Compensation Agreements
Merck
Pharmaceuticals
2011
Merck & Co., Inc. 2.250% Notes Due 2016 Officers’ Certificate
Note Agreements
Merck
Pharmaceuticals
NY
2010
Merck Sharp & Dohme Corp. Special Separation Program for 'Bridged' Employees (2009–2011)
Separation Agreements
Merck
Pharmaceuticals
2010
Merck Sharp & Dohme Corp. Special Separation Program for Separated Retirement Eligible Employees (2009–2011)
Separation Agreements
Merck
Pharmaceuticals
2010
Merck Sharp & Dohme Corp. Special Separation Program for Separated Employees (2009–2011)
Severance Agreements
Merck
Pharmaceuticals
2010
Amendment No. 4 to Call Option Agreement among Merck & Co., Merck Sharp & Dohme Corp., and Sanofi-Aventis (March 8, 2010)
Modification Agreements
Merck
Pharmaceuticals
2010
MSD Separation Benefits Plan for Nonunion Employees (Amended and Restated as of November 3, 2009)
Severance Agreements
Merck
Pharmaceuticals
NJ
2010
Merck Sharp & Dohme Corp. Special Separation Program for Separated Employees (2009–2011)
Separation Agreements
Merck
Pharmaceuticals
2010
Merck Sharp & Dohme Corp. Special Separation Program for 'Bridged' Employees (2009-2011)
Severance Agreements
Merck
Pharmaceuticals
2010
Merck Sharp & Dohme Corp. Special Separation Program for Separated Retirement Eligible Employees (2009-2011)
Separation Agreements
Merck
Pharmaceuticals
2010
Schering-Plough Corporation Severance Benefit Plan (Amended and Restated, Effective November 3, 2009)
Severance Agreements
Merck
Pharmaceuticals
2010
Schering-Plough Corporation Savings Advantage Plan (Amended and Restated as of November 4, 2009)
Compensation Agreements
Merck
Pharmaceuticals
NJ
2010
Schering-Plough Corporation Supplemental Executive Retirement Plan (Amended and Restated November 4, 2008)
Retirement Agreements
Merck
Pharmaceuticals
NJ
2010
Schering-Plough Retirement Benefits Equalization Plan (Amended and Restated as of November 4, 2009)
Retirement Agreements
Merck
Pharmaceuticals
NJ
2010
Schering-Plough Corporation Executive Life Insurance Direct Payment Program (Amended and Restated as of November 4, 2009)
Compensation Agreements
Merck
Pharmaceuticals
2010
Fifth Supplemental Indenture among Merck & Co., Inc., Merck Sharp & Dohme Corp., and The Bank of New York Mellon, dated November 3, 2009
Indenture Agreements
Merck
Pharmaceuticals
2009
Guarantor Joinder Agreement by Merck & Co., Inc. and JPMorgan Chase Bank, N.A. (November 3, 2009)
Joinder Agreements
Merck
Pharmaceuticals
NY
2009
Merck & Co., Inc. Plan for Deferred Payment of Directors' Compensation (as Amended and Restated)
Compensation Agreements
Merck
Pharmaceuticals
2009
Amendment One to Merck & Co., Inc. 2001 Non-Employee Director Stock Option Plan
Stock Agreements
Merck
Pharmaceuticals
NJ
2009
Amendment One to Merck & Co., Inc. 1996 Non-Employee Director Stock Option Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2009
Merck & Co., Inc. Schering-Plough 2006 Stock Incentive Plan (As Amended and Restated)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2009
Merck Sharp & Dohme Corp. Deferral Program and Base Salary Deferral Plan (as Amended and Restated)
Compensation Agreements
Merck
Pharmaceuticals
2009
Schering-Plough Corporation Savings Advantage Plan (Amended and Restated as of January 1, 2008)
Compensation Agreements
Merck
Pharmaceuticals
NJ
2009
Schering-Plough Corporation Supplemental Executive Retirement Plan (Amended and Restated January 1, 2008)
Retirement Agreements
Merck
Pharmaceuticals
NJ
2009
Schering-Plough Retirement Benefits Equalization Plan (Amended and Restated as of January 1, 2008)
Retirement Agreements
Merck
Pharmaceuticals
NJ
2009
Schering-Plough Corporation 2006 Stock Incentive Plan (Amended and Restated as of February 29, 2008)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2008
Employment Agreement between Schering-Plough Corporation and Brent Saunders (2006)
Employment Agreements
Merck
Pharmaceuticals
NJ
2008
Schering-Plough Corporation Severance Benefit Plan (Amended and Restated Effective January 1, 2008)
Severance Agreements
Merck
Pharmaceuticals
2008
Amendment Agreement to Distribution Agreement among Centocor, Inc., CNA Development, LLC, and Schering-Plough (Ireland) Company (December 20, 2007)
Distribution Agreements
Merck
Pharmaceuticals
2007
Underwriting Agreement for Schering-Plough Corporation Senior Notes Due 2010 and 2014
Underwriting Agreements
Merck
Pharmaceuticals
NY
2007
Fourth Supplemental Indenture between Schering-Plough Corporation and The Bank of New York (October 1, 2007)
Indenture Agreements
Merck
Pharmaceuticals
NY
2007
Share Purchase Agreement between Akzo Nobel N.V. and Schering-Plough International C.V. for Organon BioSciences N.V.
Purchase Agreements
Merck
Pharmaceuticals
2007
Underwriting Agreement for Schering-Plough Corporation Senior Notes (2017 & 2037) with Goldman Sachs, BNP Paribas, Credit Suisse, and J.P. Morgan
Underwriting Agreements
Merck
Pharmaceuticals
NY
2007
Third Supplemental Indenture between Schering-Plough Corporation and The Bank of New York (2017 and 2037 Senior Notes)
Indenture Agreements
Merck
Pharmaceuticals
NY
2007
Schering-Plough Corporation 6.00% Mandatory Convertible Preferred Stock Underwriting Agreement with Goldman, Sachs & Co. and Others (August 9, 2007)
Underwriting Agreements
Merck
Pharmaceuticals
NY
2007
Schering-Plough Corporation Common Shares Underwriting Agreement with Goldman Sachs & Co. and Others (August 9, 2007)
Underwriting Agreements
Merck
Pharmaceuticals
NY
2007
Employment Agreement between Schering-Plough Corporation and Thomas Koestler (2006)
Employment Agreements
Merck
Pharmaceuticals
NJ
2007
Employment Agreement between Schering-Plough Corporation and Raul Kohan (December 19, 2006)
Employment Agreements
Merck
Pharmaceuticals
NJ
2007
Employment Agreement between Schering-Plough Corporation and Thomas J. Sabatino, Jr. (April 15, 2004)
Employment Agreements
Merck
Pharmaceuticals
2007
Schering-Plough Corporation Change of Control Employment Agreement (Form)
Change of Control Agreements
Merck
Pharmaceuticals
2007
Schering-Plough Corporation Supplemental Executive Retirement Plan (Amended and Restated January 1, 2005)
Retirement Agreements
Merck
Pharmaceuticals
NJ
2007
Schering-Plough Corporation 2006 Stock Incentive Plan (Amended and Restated as of May 19, 2006)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2006
Schering-Plough Corporation Savings Advantage Plan (Amended and Restated as of January 1, 2006)
Profit Sharing Plans
Merck
Pharmaceuticals
NJ
2006
Schering-Plough Corporation Directors Compensation Plan (Effective June 1, 2006)
Compensation Agreements
Merck
Pharmaceuticals
NJ
2006
Schering-Plough Corporation Operations Management Team Incentive Plan (Amended and Restated June 26, 2006)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2006
Schering-Plough Corporation Savings Advantage Plan (Amended and Restated as of January 1, 2005)
Profit Sharing Plans
Merck
Pharmaceuticals
NJ
2006
Schering-Plough Retirement Benefits Equalization Plan (Amended and Restated as of January 1, 2005)
Retirement Agreements
Merck
Pharmaceuticals
2006
Schering-Plough Corporation Severance Benefit Plan (Amended and Restated, Effective December 17, 2004)
Severance Agreements
Merck
Pharmaceuticals
2005
Schering-Plough Corporation Change of Control Employment Agreement with Executive
Change of Control Agreements
Merck
Pharmaceuticals
2005
Schering-Plough Corporation Severance Benefit Plan (Amended and Restated, Effective December 17, 2004)
Severance Agreements
Merck
Pharmaceuticals
2005
Schering-Plough Retirement Benefits Equalization Plan (Amended and Restated as of January 1, 2004)
Retirement Agreements
Merck
Pharmaceuticals
2005
Schering-Plough Corporation Cash Long-Term Incentive Plan (Amended and Restated January 24, 2005)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2005
Schering-Plough Corporation Long-Term Performance Share Unit Incentive Plan (as Amended and Restated January 24, 2005)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2005
Summary of Director Compensation for Schering-Plough Board Members
Compensation Agreements
Merck
Pharmaceuticals
2005
Schering-Plough Corporation 5.30% Global Senior Note Due 2013 (Global Note)
Note Agreements
Merck
Pharmaceuticals
NY
2004
Schering-Plough Corporation 6.50% Global Senior Note Due 2033 (Global Note)
Note Agreements
Merck
Pharmaceuticals
NY
2004
Schering-Plough Executive Employment Offer Letter Agreement with Robert Bertolini
Employment Agreements
Merck
Pharmaceuticals
2004
Employment Agreement between Schering-Plough Corporation and Robert J. Bertolini (2003)
Employment Agreements
Merck
Pharmaceuticals
2004
First Amendment to Supplement to Employment Agreement between Schering-Plough Corporation and Joseph C. Connors
Employment Agreements
Merck
Pharmaceuticals
2004
Supplement to Employment Agreement between Schering-Plough Corporation and Raul Kohan (2002)
Employment Agreements
Merck
Pharmaceuticals
2004
Schering-Plough Corporation Operations Management Team Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2004
Schering-Plough Corporation Cash Long-Term Incentive Plan (Effective January 1, 2004)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2004
Schering-Plough Corporation Long-Term Performance Share Unit Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2004
Schering-Plough Corporation Transformational Performance Contingent Shares Program (2004)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2004
Distribution Agreement between Centocor, Inc. and Schering-Plough Ltd. for Infliximab (Avakine)
Distribution Agreements
Merck
Pharmaceuticals
PA
2004
Underwriting Agreement for Schering-Plough Corporation 5.300% Notes due 2013 and 6.500% Notes due 2033
Underwriting Agreements
Merck
Pharmaceuticals
NY
2003
Indenture Agreement between Schering-Plough Corporation and The Bank of New York, dated November 26, 2003
Indenture Agreements
Merck
Pharmaceuticals
NY
2003
First Supplemental Indenture for $1,250,000,000 5.30% Senior Notes due 2013 between Schering-Plough Corporation and The Bank of New York
Indenture Agreements
Merck
Pharmaceuticals
NY
2003
Second Supplemental Indenture for $1,150,000,000 6.50% Senior Notes due 2033 between Schering-Plough Corporation and The Bank of New York
Indenture Agreements
Merck
Pharmaceuticals
NY
2003
Schering-Plough Corporation Executive Incentive Plan (as Amended and Restated October 1, 2000)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2001
Amended and Restated Defined Contribution Trust Agreement between Schering-Plough Corporation and The Northern Trust Company
Trust Agreements
Merck
Pharmaceuticals
2001
Second Amendment to Schering-Plough Corporation Supplemental Executive Retirement Plan
Retirement Agreements
Merck
Pharmaceuticals
2001
Schering-Plough Corporation Deferred Compensation Plan (As Amended and Restated to October 1, 2000)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2001
Second Amendment to Schering-Plough Corporation Retirement Benefits Equalization Plan
Retirement Agreements
Merck
Pharmaceuticals
2001
2018 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Stock Agreements
Merck
Pharmaceuticals
NJ
2018
Merck & Co., Inc. 0.500% Notes Due 2024 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
NY
2016
Merck & Co., Inc. 1.375% Notes Due 2036 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2016
2013 Performance Share Unit Terms under the Merck & Co., Inc. 2010 Stock Incentive Plan
Stock Agreements
Merck
Pharmaceuticals
2015
2014 Non-Qualified Stock Option Terms for Merck & Co., Inc. Employees under the 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
NJ
2015
Merck & Co., Inc. Officers’ Certificate Establishing Terms of $300 Million Floating Rate Notes Due 2017
Note Agreements
Merck
Pharmaceuticals
NY
2015
Merck & Co., Inc. Officers’ Certificate Establishing Terms of $700 Million Floating Rate Notes Due 2020
Note Agreements
Merck
Pharmaceuticals
NY
2015
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 1.850% Notes Due 2020
Note Agreements
Merck
Pharmaceuticals
NY
2015
Merck & Co., Inc. 2.350% Notes Due 2022 Officers’ Certificate under Indenture
Indenture Agreements
Merck
Pharmaceuticals
NY
2015
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.750% Notes Due 2025
Note Agreements
Merck
Pharmaceuticals
NY
2015
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 3.700% Notes Due 2045
Note Agreements
Merck
Pharmaceuticals
NY
2015
Merck & Co., Inc. 1.125% Notes Due 2021 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2014
Merck & Co., Inc. 1.875% Notes Due 2026 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2014
Merck & Co., Inc. 2.500% Notes Due 2034 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2014
Merck & Co., Inc. 0.700% Notes Due 2016 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. Officers’ Certificate for $500 Million Floating Rate Notes Due 2016
Note Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. Officers’ Certificate for 1.300% Notes Due 2018 under Indenture
Indenture Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. Officers’ Certificate for $1 Billion Floating Rate Notes Due 2018
Indenture Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.800% Notes Due 2023
Note Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. 4.150% Notes Due 2043 Officers’ Certificate
Note Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. 2010 Incentive Stock Plan Non-Qualified Stock Option Terms (2013 Onward)
Stock Agreements
Merck
Pharmaceuticals
NJ
2013
Merck & Co., Inc. U.S. Separation Benefits Plan (Effective January 1, 2013)
Severance Agreements
Merck
Pharmaceuticals
NJ
2013
Merck & Co., Inc. Change in Control Separation Benefits Plan (Amended and Restated as of January 1, 2013)
Change of Control Agreements
Merck
Pharmaceuticals
NJ
2012
Merck & Co., Inc. 1.100% Notes Due 2018 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. 2.400% Notes Due 2022 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
NY
2012
Merck & Co., Inc. 3.600% Notes Due 2042 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. U.S. Separation Benefits Plan (Effective January 1, 2012)
Severance Agreements
Merck
Pharmaceuticals
NJ
2012
MSD Separation Benefits Plan for Nonunion Employees (Amended and Restated as of October 1, 2010)
Severance Agreements
Merck
Pharmaceuticals
NJ
2011
Indenture Agreement between Merck & Co., Inc. and U.S. Bank Trust National Association, dated January 6, 2010
Indenture Agreements
Merck
Pharmaceuticals
NY
2010
Merck & Co., Inc. 3.875% Notes Due 2021 Officers’ Certificate
Note Agreements
Merck
Pharmaceuticals
NY
2010
Amendment One to Merck & Co., Inc. Change in Control Separation Benefits Plan
Change of Control Agreements
Merck
Pharmaceuticals
2010
Amendment One to Merck Sharp & Dohme Corp. 2007 Incentive Stock Plan (As Amended and Restated as of November 3, 2009)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2010
Non-Qualified Stock Option Terms under Merck Sharp & Dohme Corp. 2007 and Schering-Plough 2006 Stock Incentive Plans
Stock Agreements
Merck
Pharmaceuticals
2010
2010 Restricted Stock Unit Terms under Merck Sharp & Dohme Corp. 2007 Incentive Stock Plan and Schering-Plough 2006 Stock Incentive Plan
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2010
Second Supplemental Indenture among Merck Sharp & Dohme Corp., Merck & Co., Inc., and U.S. Bank Trust National Association, dated November 3, 2009
Indenture Agreements
Merck
Pharmaceuticals
2009
Amendment No. 1 to Amended and Restated Five-Year Credit Agreement among Merck & Co., Inc., Lenders, and Citicorp USA, Inc. (April 20, 2009)
Credit Agreements
Merck
Pharmaceuticals
NY
2009
Guarantee and Joinder Agreement between Merck & Co., Inc. and Citicorp USA, Inc. (as Administrative Agent) and Lenders, dated November 3, 2009
Guaranty Agreements
Merck
Pharmaceuticals
2009
Merck & Co., Inc. 2006 Non-Employee Director Stock Option Plan (Amended and Restated)
Stock Agreements
Merck
Pharmaceuticals
NJ
2009
Merck Sharp & Dohme Corp. 2007 Incentive Stock Plan (as Amended and Restated)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2009
Amendment One to Merck & Co., Inc. 2004 Incentive Stock Plan (as Amended and Restated December 19, 2006)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2009
Amendment One to Merck & Co., Inc. 2001 Incentive Stock Plan (as Amended and Restated)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2009
Amendment One to Merck & Co., Inc. 1996 Incentive Stock Plan (as Amended and Restated December 19, 2006)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
2009
Merck & Co., Inc. Change in Control Separation Benefits Plan (Amended and Restated)
Change of Control Agreements
Merck
Pharmaceuticals
NJ
2009
Agreement and Plan of Merger among Merck & Co., Inc., Schering-Plough Corporation, Blue, Inc., and Purple, Inc. (March 8, 2009)
Merger Agreements
Merck
Pharmaceuticals
NJ
2009
Schering-Plough Corporation 2006 Stock Incentive Plan (Amended and Restated as of January 1, 2009)
Bonus & Incentive Agreements
Merck
Pharmaceuticals
NJ
2009
Change of Control Employment Agreement between Schering-Plough Corporation and Executive
Change of Control Agreements
Merck
Pharmaceuticals
2009